PAPER Lashuel HA, Mahul-Mellier AL, Novello S, Hegde RN, Jasiqi Y, Altay MF, Donzelli S, DeGuire SM, Burai R, Magalhães P, Chiki A, Ricci J, Boussouf M, Sadek A, Stoops E, Iseli C, Guex N

Neighbouring modifications interfere with the detection of phosphorylated alpha-synuclein at Serine 129: Revisiting the specificity of pS129 antibodies

bioRxiv, March 31, 2022 . bioRxiv

PAPER Mahul-Mellier AL, Altay MF, Burtsche J, Maharjan N, Ait-Bouziad N, Chiki A, Vingill S, Wade-Martins R, Holton J, Strand C, Haikal C, Li JY, Hamelin R, Croisier M, Knott G, Mairet-Coello G, Weerens L, Michel A, Downey P, Citron M, Lashuel HA

The making of a Lewy body: the role of α-synuclein post-fibrillization modifications in regulating the formation and the maturation of pathological inclusions

bioRxiv. December 19, 2018 . bioRxiv

PAPER Jin M, Xu R, Alam MM, Ma Z, Zhu S, Wang L, Martini AC, Bernabucci M, Xie P, Kwan K, Pang ZP, Head E, Liu Y, Hart RP, Jiang P

Type I Interferon Signaling Drives Microglial Dysfunction and Senescence in Human iPSC Models of Down Syndrome and Alzheimer’s Disease

bioRxiv. December 23, 2021 . bioRxiv

PAPER Kousi M, Boix C, Park YP, Mathys H, Sledzieski S, Peng Z, Bennett DA, Tsai LH, Kellis M

Single-cell mosaicism analysis reveals cell-type-specific somatic mutational burden in Alzheimer’s Dementia

bioRxiv. April 22, 2022 . bioRxiv

PAPER Goldfine A, Faulkner R, Sadashivam V, Omidvar O, Hill J, Jagadeesan S, Sharma A, Yao SL

Results of a Phase 1 Dose-Ranging Trial, and Design of a Phase 2 Trial, of K0706, a Novel C-Abl Tyrosine Kinase Inhibitor for Parkinson’s Disease. (P2.8-047)

Neurology Supplement, April 6, 2019 . Neurology Supplement

PAPER Lee YF, Russ AN, Zhao Q, Maci M, Miller MR, Hou SS, Algamal M, Araque A, Galea E, Bacskai BJ, Kastanenka K

Optogenetic Targeting of Astrocytes Restores Sleep-Dependent Brain Rhythm Function and Slows Alzheimer's Disease

Cell Reports, 8 Apr 2022 . Cell Reports

PAPER Shah D, Gsell W, Wahis J, Luckett ES, Jamoulle T, Vermaercke B, Preman P, Moechars D, Hendrickx V, Jaspers T, Craessaerts K, Horré K, Wolfs L, Fiers M, Holt M, Thal DR, Callaerts-Vegh Z, D’Hooge R, Vandenberghe R, Himmelreich U, Bonin V, De Strooper B

Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer’s Disease

bioRxiv, April 26, 2022 . bioRxiv

PAPER Dodd DA, LaCroix M, Valdez C, Knox GM, Vega AR, Kumar A, Xing C, White CL, Diamond MI

Tau seeds translocate across the cell membrane to initiate aggregation

medRxiv, May 12, 2022 .

PAPER Bressan E, Reed X, Bansal V, Hutchins E, Cobb MM, Webb MG, Alsop E, Grenn FP, Illarionova A, Savytska S, Violich I, Broeer S, Fernandes N, Sivakumar R, Beilina A, Billingsley K, Berghausen J, Pantazis CB, Meechoovet B, Reiman R, Courtright-Lim A, Logemann A, Antone J, Barch M, Kitchen R, Li Y, Dalgard CL, The American Genome Center, Rizzu PR, Hernandez DG, Hjelm BE, Nalls M, Gibbs JR, Finkbeiner S, Cookson MR, Van Keuren-Jensen K, Craig DW, Singleton AB, Heutink P, Blauwendraat C

The Foundational data initiative for Parkinson’s disease (FOUNDIN-PD): enabling efficient translation from genetic maps to mechanism

BioRxiv, June 3, 2021 . bioRxiv

PAPER Wang Q, Wang M, Choi I, Ho L, Farrell K, Beaumont KG, Sebra R, Crary JF, Davis DA, Sun X, Zhang B, Yue Z

Single-cell transcriptomic atlas of the human substantia nigra in Parkinson’s disease

bioRxiv. March 30, 2022 . bioRxiv

PAPER Padda IS, Parmar M

Aducanumab

Time Pearls / Treasure Island, January 22, 2022 . Stat Pearls / Treasure Island

PAPER Mann AW, Gregg RE, Ronan R, Fairwell T, Hoeg JM, Brewer HB

Apolipoprotein E-1 Harrisburg, a mutation in the receptor binding domain, that is dominant for dysbetalipoproteinemia results in defective ligand-receptor interactions

Clin. Res. 37:520A. (Abstr.), 1989 . National Library of Medicine

PAPER Wieland H, Funke H, Krieg J, Luley C

ApoE3-Freiburg and apoE4-Freiburg are two genetic apoE variants which are caused by exchanges of uncharged amino acids and do not appear to be associated with lipid disorders or heart disease. Abstract

Book of the Ninth International Symposium on Atherosclerosis. Rosemont, Illinois 1991. P. 164. .

PAPER Sauvé F, Ternier G, Dewisme J, Lebouvier T, Dupré E, Danis C, Rasika S, Kim YB, Ciofi P, Giacobini P, Buée L, Landrieu I, Pasquier F, Maurage CA, Nogueiras R, Schwaninger M, Prevot V

Tanycytes are degraded in Alzheimer’s Disease, disrupting the brain-to-blood efflux of Tau

medRxiv, May 7, 2022 . medRxiv

PAPER Nutma E, Fancy N, Weinert M, Marzin MC, Tsartsalis S, Muirhead RCJ, Falk I, de Bruin J, Hollaus D, Pieterman R, Anink J, Story D, Chandran S, Tang J, Trolese MC, Saito T, Saido TC, Wiltshire K, Beltran-Lobo P, Philips A, Antel J, Healy L, Moore CS, Bendotti C, Aronica E, Radulescu CI, Barnes SJ, Hampton DW, van der Valk P, Jacobson S, Matthews PM, Amor S, Owen DR

Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases

bioRXiv. 2022 May 11 . bioRxiv